代谢手术与药物治疗2型糖尿病的患者报告结局:STAMPEDE随机试验
STAMPEDE随机试验比较Roux-en-Y胃旁路术(RYGB)、袖状胃切除术(SG)与强化药物治疗(IMT)对2型糖尿病(T2DM)患者报告结局(PROs)的长期影响。104例患者完成RAND-36、EQ-5D-3L及糖尿病特异性问卷随访至5年,结果显示RYGB和SG在躯体功能、总体健康感知、精力/疲劳及糖尿病相关生活质量方面显著优于IMT,而心理社会维度无显著组间差异。
要点
- RYGB和SG在躯体健康及糖尿病相关生活质量方面较IMT显著改善。
- 心理社会生活质量在各治疗组间无显著长期差异。
- 5年胰岛素非依赖与总体健康感知改善独立相关。
核心结论
- 在T2DM患者中,代谢手术与IMT相比在部分PROs方面有长期有利变化,主要在躯体健康和糖尿病相关领域。
- 代谢手术后心理社会健康值得更多关注。
研究设计与样本
- STAMPEDE随机试验中104例患者的子集,在基线及随机化后每年至5年接受RAND-36、EQ-5D-3L和糖尿病特异性问卷评估。
主要发现
- 纵向分析显示RYGB和SG在躯体功能、总体健康感知、精力/疲劳及糖尿病相关生活质量领域较IMT组显著改善。
- IMT组通用问卷中无任何生活质量组分较基线显著改善。
- 各研究组在心理和社会方面生活质量指标上无显著长期差异。
- 多变量分析中,与长期总体健康感知改善独立相关的因素包括基线总体健康(P < 0.001)、5年胰岛素非依赖(P = 0.005)、RYGB vs IMT(P = 0.005)和SG vs IMT(P = 0.034)。
- RYGB和SG后的有利变化相当。
临床怎么用
- 代谢手术应被视为可在躯体健康和糖尿病相关生活质量方面带来长期获益的治疗选择。
- 术后管理需关注心理社会健康,即使躯体健康改善。
- 5年胰岛素非依赖与总体健康感知改善独立相关,提示代谢控制与PROs的关联。
局限性
- PROs分析基于104例患者的子集。
- 未报告心理社会干预对PROs的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to investigate the long-term effects of medical and surgical treatments of type 2 diabetes mellitus (T2DM) on patient-reported outcomes (PROs). BACKGROUND: Robust data on PROs from randomized trials comparing medical and surgical treatments for T2DM are lacking. METHODS: The Surgical Treatment And Medications Potentially Eradicate Diabetes Efficiently (STAMPEDE) trial showed that 5 years after randomization, Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) were superior to intensive medical therapy (IMT) alone in achieving glycemic control in patients with T2DM and obesity. A subset of 104 patients participating in the STAMPEDE trial were administered two generic health-related quality of life (QoL) questionnaires (RAND-36 and EQ-5D-3L) and a diabetes-specific instrument at baseline, and then on an annual basis up to 5 years after randomization. RESULTS: On longitudinal analysis, RYGB and SG significantly improved the domains of physical functioning, general health perception, energy/fatigue, and diabetes-related QoL compared with IMT group. In the IMT group, none of the QoL components in the generic questionnaires improved significantly from baseline. No significant long-term differences were observed among the study groups in measures of psychological and social aspects of QoL. On multivariable analysis, independent factors associated with improved general health perception at long-term included baseline general health (P < 0.001), insulin independence at 5 years (P = 0.005), RYGB versus IMT (P = 0.005), and SG versus IMT (P = 0.034). Favorable changes following RYGB and SG were comparable. CONCLUSIONS: In patients with T2DM, metabolic surgery is associated with long-term favorable changes in certain PROs compared with IMT, mainly on physical health and diabetes-related domains. Psychosocial well-being warrants greater attention after metabolic surgery.
引用
- Aminian A, Kashyap SR, Wolski KE, et al. Patient-reported Outcomes After Metabolic Surgery Versus Medical Therapy for Diabetes: Insights From the STAMPEDE Randomized Trial. Ann Surg. 2021. PMID: 34132694. doi:10.1097/SLA.0000000000005003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。